Seungwon Kim

University of Pittsburgh — United States

Medicine · Health Sciences

45h-index7.2kcitations237works3.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(103), Head and Neck Surgical Oncology(42), Lung Cancer Treatments and Mutations(39), Cancer Immunotherapy and Biomarkers(29), Cytokine Signaling Pathways and Interactions(24)

Publications234 total

Supplemental Table 3 from Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
2025Open Access
Supplemental Figure 1 from Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
2025Open Access
Supplemental Table 2 from Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
2025Open Access
Supplemental Figure 2 from Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
2025Open Access
Supplemental Table 4 from Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
2025Open Access
Supplemental Table 1 from Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit
2025Open Access
Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer
Oral Oncology·2025· 1 citedOpen Access
Facial Vein Ligation is Associated with Lymphedema Among Patients with Head and Neck Cancer Undergoing Surgery and Radiation
Annals of Surgical Oncology·2025· 1 cited
What Is the Role of Immunotherapy in Patients With Cutaneous Squamous Cell Carcinoma?
The Laryngoscope·2025
Two-team approaches in modern head and neck oncologic and reconstructive surgery: ablative considerations
Current Opinion in Otolaryngology & Head & Neck Surgery·2025
Preoperative Care Clinic Improves Survival for Patients Undergoing Free‐Flap Reconstruction
Otolaryngology·2025Open Access
Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck Cancer
2025· 1 citedOpen Access
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer
Journal of Clinical Oncology·2025· 7 cited
Neuregulin-induced HER3 activation drives migration in head and neck squamous cell carcinoma via HER2 and FAK signaling pathways
Cellular Oncology·2025· 5 citedOpen Access
Abstract 5804: Pathologic responses to neoadjuvant immune checkpoint inhibitor (ICI) combinations in head and neck squamous cell carcinoma (HNSCC) associate with specific CD4+ helper and regulatory T cell activation states and clonal plasticity
Cancer Research·2025
Neuregulin-Induced HER3 Activation Drives Migration in Head and Neck squamous cell carcinoma via HER2 and FAK Signaling Pathways
2025Open Access
Mucoepidermoid Carcinoma Associated with an Intercalated Duct Lesion: Precursor or Coincidence?
Head and Neck Pathology·2025Open Access
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
Cancer Cell·2025· 37 citedOpen Access
Towards improved speech and swallowing outcomes after hemiglossectomy reconstruction: Impact of neurotization and free flap choice
Oral Oncology·2024
493 Distinct correlative signatures of CD4<sup>+</sup> helper and regulatory T cells associate with response to different neoadjuvant immune checkpoint inhibitor combinations in HNSCC
Regular and Young Investigator Award Abstracts·2024Open Access
page 1 of 12Next →

Frequent Co-authors

Robert L. Ferris(31), Umamaheswar Duvvuri(26), Jonas T. Johnson(22), Simion I. Chiosea(9), Jeffrey N. Myers(9), Samar A. Jasser(8), William E. Gooding(7), William G. Albergotti(7), Jennifer R. Grandis(6), Maher N. Younes(6), Barton F. Branstetter(6), Raja R. Seethala(5), Adel K. El‐Naggar(5), James Ohr(5), Julie E. Bauman(5), Dwight E. Heron(5), Yasemin D. Yazici(5), Jessica H. Maxwell(4), Vikas Mehta(4), Mahitosh Mandal(4)